Clinical Trials · NCT07765160
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
- Phase
- Phase 1
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Enrollment
- 96
- Start date
- Aug 2026
- Locations
- 1 site, China
- Primary endpoint
- SAD: The incidence rate of adverse events (AE)